C3 and inflammatory bowel disease: Additional evidence of complement activation at the protein level in patients with IBD came from a study by Ueki and collaborators, which investigated the expression of C3 activation and degradation products, terminal complement complex (TCC), and complement regulatory proteins in biopsies from patients with IBD.